Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 18, Issue 8, 2003, Pages 1535-1540

  Moczulski, Dariusz ^a   Fojcik, Hanna ^a   Zukowska Szczechowska, Ewa ^a   Szydlowska, Ilona ^a   Grzeszczak, Wladyslaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diabetic nephropathy; Genetic susceptibility; Homocysteine; MTHFR; Type 2 diabetes mellitus

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALBUMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CHRONIC KIDNEY FAILURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA ANALYSIS; DIABETIC NEPHROPATHY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; STAGING; VITAMIN INTAKE;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY FUNCTION TESTS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0043166547     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg211     Document Type: Article

References (19)

1. Ralph C, Jacobsen DW. Homocysteine in Health and Disease. Cambridge University Press, Cambridge, UK, 2001; 92-112
2. Neugebauer S, Baba T, Watanabe T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 1998; 352: 454
3. Noiri E, Taguchi JI, Nakao A, Fujita T. MTHFR gene polymorphism. as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients. Diabetes Care 2000; 23: 260
4. Isotalo PA, Donnelly JG. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 2000; 5: 59-66
5. Okada E, Oida K, Tada H et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 1999; 22: 484-490
6. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi J, Costa FF. The mutation C677T in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77: 818-821
7. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395-1398
8. van der Put NMJ, Gabreels F, Stevens EM et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051
9. Frost P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 1995; 10: 111-113
10. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes in the prevalence of stages of diabetic nephropathy defined by albumin/creatinine ratio. J Am Soc Nephrol 1996; 7: 930-937
11. Bald E, Kaniowska E, Chwatko G, Glowacki R. Liquid chromatographic assessment of total and protein-bound homocysteine in human plasma. Talanta 2000; 50: 1233-1243
12. Szczeklik A, Sanak M, Jankowski M et al. Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia. Am J Med Genet 2001; 101: 36-39
13. Rozen R. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inher Metab Dis 1996; 19: 589-594
14. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Gen Methab 1998; 64: 169-172
15. Christensen PK, Larsen S, Horn T, Olsen S. Causes of albuminuria in patients with type 2 diabetes without diabetic nephropathy. Kindey Int 2000; 58: 1719-1731
16. Ralph C, Jacobsen DW. Homocysteine in Health and Disease. Cambridge University Press, Cambridge, UK, 2001; 341-355
17. Dierkes J, Jeckel A, Ambrosch A, Westphal S, Luley C, Boeing H. Factors explaining the difference of total homocysteine between men and women in European Investigation Into Cancer and Nutrition Potsdam study. Metabolism 2001; 50: 640-645
18. van der Mooren MJ, Demacker PN, Blom HJ, de Rijke YB, Rolland R. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil Steril 1997; 67: 63-73
19. Ralph C, Jacobsen DW. Homocysteine in Health and Disease. Cambridge University Press, Cambridge, UK, 2001; 321-330